Abstract No. 8: Downstaging locally advanced pancreatic adenocarcinoma (LAPC) with vascular encasement using percutaneous irreversible electroporation (IRE)
Narayanan, G, Arora, G, Barbery, K.J, Froud, T, Livingstone, A, Franceschi, D, Hosein, P, Rocha Lima, C.M, Yrizarry, J
Published in Journal of vascular and interventional radiology (01.03.2012)
Published in Journal of vascular and interventional radiology (01.03.2012)
Get full text
Journal Article
Myelopreservation with the CDK4/6 inhibitor trilaciclib in patients with small-cell lung cancer receiving first-line chemotherapy: a phase Ib/randomized phase II trial
Weiss, J.M., Csoszi, T., Maglakelidze, M., Hoyer, R.J., Beck, J.T., Domine Gomez, M., Lowczak, A., Aljumaily, R., Rocha Lima, C.M., Boccia, R.V., Hanna, W., Nikolinakos, P., Chiu, V.K., Owonikoko, T.K., Schuster, S.R., Hussein, M.A., Richards, D.A., Sawrycki, P., Bulat, I., Hamm, J.T., Hart, L.L., Adler, S., Antal, J.M., Lai, A.Y., Sorrentino, J.A., Yang, Z., Malik, R.K., Morris, S.R., Roberts, P.J., Dragnev, K.H.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A randomized, placebo-controlled phase 2 study of ganitumab (AMG 479) or conatumumab (AMG 655) in combination with gemcitabine in patients with metastatic pancreatic cancer
Kindler, H.L., Richards, D.A., Garbo, L.E., Garon, E.B., Stephenson, J.J., Rocha-Lima, C.M., Safran, H., Chan, D., Kocs, D.M., Galimi, F., McGreivy, J., Bray, S.L., Hei, Y., Feigal, E.G., Loh, E., Fuchs, C.S.
Published in Annals of oncology (01.11.2012)
Published in Annals of oncology (01.11.2012)
Get full text
Journal Article
Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer
Wolpin, B.M., O'Reilly, E.M., Ko, Y.J., Blaszkowsky, L.S., Rarick, M., Rocha-Lima, C.M., Ritch, P., Chan, E., Spratlin, J., Macarulla, T., McWhirter, E., Pezet, D., Lichinitser, M., Roman, L., Hartford, A., Morrison, K., Jackson, L., Vincent, M., Reyno, L., Hidalgo, M.
Published in Annals of oncology (01.07.2013)
Published in Annals of oncology (01.07.2013)
Get full text
Journal Article
Phase II trial of irinotecan/gemcitabine as second-line therapy for relapsed and refractory small-cell lung cancer: Cancer and Leukemia Group B Study 39902
Rocha-Lima, C.M., Herndon, J.E., Lee, M.E., Atkins, J.N., Mauer, A., Vokes, E., Green, M.R.
Published in Annals of oncology (01.02.2007)
Published in Annals of oncology (01.02.2007)
Get full text
Journal Article
Randomized phase II trial of gemcitabine plus irinotecan or docetaxel in stage IIIB or stage IV NSCLC
Rocha Lima, C. M., Rizvi, N. A., Zhang, C., Herndon, J. E., Crawford, J., Govindan, R., King, G. W., Green, M. R.
Published in Annals of oncology (01.03.2004)
Published in Annals of oncology (01.03.2004)
Get full text
Journal Article